A Boost for Biotechnology and Healthcare
The slump in biotechnology and healthcare could present a buying opportunity. Biotechnology stocks and biotech ETFs tumbled in the back half of March and to start April. For example, the SPDR S&P Biotech ETF (NYSEArca: XBI) came into. Continue reading